IBM
53
2
ABT
54
4
FOXA
67
5
AAPL
64
3
FTI
61
5
PBI
30
-8
KLAC
45
3
JWN
72
9
LH
33
3
FMC
23
7
CCI
30
2
VRSN
59
4
HBAN
47
7
EXPD
29
2
BIIB
36
8
WU
26
2
XRX
48
2
STT
48
4
CRM
65
6
OMC
37
2
IBM
53
2
ABT
54
4
FOXA
67
5
AAPL
64
3
FTI
61
5
PBI
30
-8
KLAC
45
3
JWN
72
9
LH
33
3
FMC
23
7
CCI
30
2
VRSN
59
4
HBAN
47
7
EXPD
29
2
BIIB
36
8
WU
26
2
XRX
48
2
STT
48
4
CRM
65
6
OMC
37
2
Financhill
Back

Cytokinetics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

CYTK
Cytokinetics

Last Price:
$48.90
Seasonality Move:
7.19%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.3% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $48.96. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.3% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Sell
42
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
43.21

Prediction Charts

Market Cap:
5.8B
Price in USD:
48.96
Volume:
3.5M
Beta:
1.44

Technical Analysis

SMA50:
52.00
SMA100:
53.59
SMA200:
57.10
52-Wk Change:
37.07%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 48.96 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 50.52 51.51 51.80 49.95
Dec-4 51.21 50.44 51.53 50.38
Dec-5 49.78 50.40 50.65 49.73
Dec-6 50.57 50.96 51.98 50.15
Dec-9 51.18 50.50 51.71 50.21
Dec-10 50.38 50.55 51.26 50.12
Dec-11 50.42 50.70 50.90 49.84
Dec-12 50.29 50.24 50.68 49.52
Dec-13 50.10 48.65 50.24 48.14
Dec-16 48.61 49.02 49.58 48.54
Dec-17 48.50 47.78 49.04 47.38
Dec-18 48.00 46.36 49.40 46.00
Dec-19 46.45 46.74 47.30 45.66
Dec-20 46.85 48.96 50.32 46.85

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.02 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.